ANALYSIS OF PRIMARY BREAST CANCER (BC) EXPRESSION OF PROGRAMMED CELL DEATH 1 (PD-1) RECEPTOR AND PROGRAMMED DEATH LIGAND 1 (PD-L1) TO DETERMINE ASSOCIATIONS WITH CLINICAL CHARACTERISTICS AND OUTCOMES

Vidula Neelima; Yau Christina; Goga Andrei; Rugo Hope S.

首页> 外文期刊>The Breast : >ANALYSIS OF PRIMARY BREAST CANCER (BC) EXPRESSION OF PROGRAMMED CELL DEATH 1 (PD-1) RECEPTOR AND PROGRAMMED DEATH LIGAND 1 (PD-L1) TO DETERMINE ASSOCIATIONS WITH CLINICAL CHARACTERISTICS AND OUTCOMES

【24h】

ANALYSIS OF PRIMARY BREAST CANCER (BC) EXPRESSION OF PROGRAMMED CELL DEATH 1 (PD-1) RECEPTOR AND PROGRAMMED DEATH LIGAND 1 (PD-L1) TO DETERMINE ASSOCIATIONS WITH CLINICAL CHARACTERISTICS AND OUTCOMES

机译：分析已编程细胞死亡1（PD-1）受体和已编程死亡配体1（PD-L1）的原发性乳腺癌（BC）表达，以确定具有临床特征和结果的关联

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Breast : 》 |2015年第3期| 共5页
作者
Vidula Neelima; Yau Christina; Goga Andrei; Rugo Hope S.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类胸部外科学 ;
关键词

相似文献

外文文献
中文文献
专利

1. ANALYSIS OF PRIMARY BREAST CANCER (BC) EXPRESSION OF PROGRAMMED CELL DEATH 1 (PD-1) RECEPTOR AND PROGRAMMED DEATH LIGAND 1 (PD-L1) TO DETERMINE ASSOCIATIONS WITH CLINICAL CHARACTERISTICS AND OUTCOMES [J] . Vidula Neelima, Yau Christina, Goga Andrei, The Breast : . 2015 ,第Suppla3期

机译：分析已编程细胞死亡1（PD-1）受体和已编程死亡配体1（PD-L1）的原发性乳腺癌（BC）表达，以确定具有临床特征和结果的关联
2. Programmed Death Ligand-1 (PD-L1) Expression in the Programmed Death Receptor-1 (PD-1)/PD-L1 Blockade A Key Player Against Various Cancers [J] . Guan Jian, Lim Khin Sandar, Mekhail Tarek, Archives of pathology & laboratory medicine . 2017 ,第6期

机译：编程死亡受体-1（PD-1）/ PD-L1中的编程死亡配体-1（PD-L1）表达阻断了针对各种癌症的关键播放器
3. Clinical and pathological significance of programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) expression in high grade serous ovarian cancer [J] . Y?lmaz Ba?, Nermin Ko?, Kaan Helvac?, Translational Oncology . 2021 ,第2期

机译：编程细胞死亡1（PD-1）/编程细胞死亡配体1（PD-L1）表达的临床和病理意义，高级浆液癌中表达
4. Molecular dynamics of the immune checkpoint Programmed Cell Death Protein I, PD-1: Conformational changes of the BC-loop upon binding of the ligand PD-L1 and the monoclonal antibody nivolumab [C] . Bernhard Roither, Chris Oostenbrink, Wolfgang Schreiner IEEE International Conference on Bioinformatics and Biomedicine . 2019

机译：免疫检查点的分子动力学程序性细胞死亡蛋白I，PD-1：配体PD-L1与单克隆抗体nivolumab结合后BC环的构象变化
5. Pattern of programmed cell death-ligand 1 expression and CD8-positive T-cell infiltration before and after chemoradiotherapy in rectal cancer [D] . Ogura Atsushi, 小倉淳司 2019

机译：直肠癌放化疗前后程序性细胞死亡配体1表达和CD8阳性T细胞浸润的模式
6. Outcomes of Programmed Cell Death Protein 1 (PD-1) and Programmed Death-Ligand 1(PD-L1) Inhibitor Therapy in HIV Patients with Advanced Cancer [O] . Shahla Bari, Jameel Muzaffar, Austin Chan, 2019

机译：HIV晚期癌症患者程序性细胞死亡蛋白1（PD-1）和程序性死亡配体1（PD-L1）抑制剂治疗的结果
7. Outcomes of Programmed Cell Death Protein 1 (PD-1) and Programmed Death-Ligand 1(PD-L1) Inhibitor Therapy in HIV Patients with Advanced Cancer [O] . Shahla Bari, Jameel Muzaffar, Austin Chan, 2019

机译：编程的细胞死亡蛋白1（PD-1）和编程死亡 - 配体1（PD-L1）抑制剂治疗患者的先进癌症的结果

ANALYSIS OF PRIMARY BREAST CANCER (BC) EXPRESSION OF PROGRAMMED CELL DEATH 1 (PD-1) RECEPTOR AND PROGRAMMED DEATH LIGAND 1 (PD-L1) TO DETERMINE ASSOCIATIONS WITH CLINICAL CHARACTERISTICS AND OUTCOMES

著录项

相似文献

相关主题

期刊订阅